Cargando…

Optimal management of giant cell arteritis and polymyalgia rheumatica

Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are clinical diagnoses without “gold standard” serological or histological tests, excluding temporal artery biopsy for GCA. Further, other conditions may mimic GCA and PMR. Treatment with 10–20 mg of prednisolone daily is suggested for PMR...

Descripción completa

Detalles Bibliográficos
Autor principal:	Charlton, Rodger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333461/ https://www.ncbi.nlm.nih.gov/pubmed/22547936 http://dx.doi.org/10.2147/TCRM.S13088

Ejemplares similares

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Genetic epidemiology: Giant cell arteritis and polymyalgia rheumatica
por: Gonzalez-Gay, Miguel A
Publicado: (2001)

Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients
por: Ramon, André, et al.
Publicado: (2022)

Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update
por: Nesher, Gideon, et al.
Publicado: (2016)

Liver involvement in polymyalgia rheumatica and giant cell arteritis
por: Hysa, Elvis, et al.
Publicado: (2020)

Giant cell arteritis with polymyalgia rheumatica on FDG‐PET/CT
por: Baba, Akira, et al.
Publicado: (2017)

Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
por: Milchert, Marcin, et al.
Publicado: (2020)

Giant Cell Arteritis Mimicking Polymyalgia Rheumatica: A Challenging Diagnosis
por: Ohta, Ryuichi, et al.
Publicado: (2022)

Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
por: Low, Candice, et al.
Publicado: (2023)

Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis
por: Smutny, Tomas, et al.
Publicado: (2019)

Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis
por: Manzo, Ciro, et al.
Publicado: (2021)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2023)

Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?
por: Toussirot, Éric, et al.
Publicado: (2016)

The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population
por: Yates, Max, et al.
Publicado: (2016)

Polymyalgia rheumatica and giant cell arteritis with intracranial involvement postvaccination anti-COVID-19
por: Arias, Manuel, et al.
Publicado: (2022)

Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2016)

Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2019)

Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
por: Gisslander, Karl, et al.
Publicado: (2023)

New-Onset Polymyalgia Rheumatica Complicated by Giant Cell Arteritis Following COVID-19 Infection
por: Mamootil, Divya
Publicado: (2023)

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
por: van der Geest, Kornelis S. M., et al.
Publicado: (2022)

An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022)

Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series
por: Diamantopoulos, Andreas P., et al.
Publicado: (2013)

Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study
por: Paskins, Zoe, et al.
Publicado: (2018)

A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon, Elizabeth, et al.
Publicado: (2019)

Atypical Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Polymyalgia Rheumatica and Giant Cell Arteritis
por: FALSETTI, PAOLO, et al.
Publicado: (2021)

Normal ESR, CRP and Platelet Count in Giant Cell Arteritis and Polymyalgia Rheumatica: A Diagnostic Conundrum
por: Mahgoub, Abdullahi Elsheikh, et al.
Publicado: (2022)

A Case Report of Post COVID19 Giant Cell Arteritis and Polymyalgia Rheumatica With Visual Loss
por: Mursi, Ali M, et al.
Publicado: (2022)

Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank
por: Chatzigeorgiou, Charikleia, et al.
Publicado: (2023)

Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969)

Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)

Association of FCGR2A and Fc gamma receptor haplotypes with Spanish polymyalgia rheumatica and giant cell arteritis
por: Morgan, AW, et al.
Publicado: (2005)

AZD-1222/mRNA-1273/tozinameran: Polymyalgia rheumatica or giant cell arteritis: 3 case reports
Publicado: (2021)

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica – a prospective cohort study
por: Burg, Lara C., et al.
Publicado: (2023)

Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2023)

Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis
por: Pacoureau, Lucas, et al.
Publicado: (2023)

Polymyalgia rheumatica: An update (Review)
por: Florescu, Mirela Marinela, et al.
Publicado: (2023)

Giant cell arteritis with cervical radiculopathy mimicking polymyalgia rheumatica and elderly-onset rheumatoid arthritis: a case report
por: Nakabayashi, Akihiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fe7isep9e0lhkpagi2uabvrej7